Author:
Kaur RP,Ho GF,Mastura MY,Goh PP,Salowi Mohamad Aziz,Muhd. Radzi AH,Hau Anwar,Sathar Jameela,Robaayah Z,Selladurai Benedict,Suleiman Abu Bakar,Morad Zaki,Ghazali A,Lim TO
Abstract
AbstractBackgroundUpper middle income countries have made substantial progress towards universal health coverage. We investigated whether the coverage extended to diseases that incur catastrophic health spending, the contribution of pooled financing and the factors driving it in Malaysia.MethodsWe adapted the WHO definition of catastrophic health spending to define costly treatment as one that cost, at prevailing market price, more than 10% of the median annual household income in Malaysia. Coverage is defined as the proportion of patients in a year who were in need of a treatment and who received it. Data to estimate coverage and financing were extracted from the published and grey literature, as well as secondary data sources available on disease epidemiology and healthcare in Malaysia.ResultsWe found coverage varies from universal for dialysis, cataract surgery, medicines for organ transplant and CML, to practically none for HCV, stroke, psoriasis and epilepsy surgery. Coverage of targeted therapies for solid cancers, knee replacement surgery, anti-TNF for arthritis and coagulation factors for haemophilia were poor while iron chelation for thalassemia, coronary revacularization, epoetin and anti-retrovirals were barely adequate. Coverage correlates negatively (r=-0.82) with health benefits foregone, and is entirely driven by the contribution of pooled financing (r=0.99 p<0.0001). The relative effectiveness of a treatment, its budget impact, media coverage and political influence of the disease area have little influence on financing. Only effectiveness of the leadership representing the therapy area is influential; an increase in one point on the leadership effectiveness scale is associated with 30% increase in the contribution of pooled financing.ConclusionCoverage for catastrophically costly treatments is uneven and inequitable in Malaysia, despite most of these are affordable. Decisions on coverage are driven by political-economic consideration.
Publisher
Cold Spring Harbor Laboratory
Reference60 articles.
1. WHO. World Health Report 2010. Health systems financing. Path to universal coverage. Geneva: World Health Organization, 2010
2. Moving towards universal health coverage: lessons from 11 country studies
3. Dieleman JL , Templin T , Sadat N , et al. 2016. National spending on health by source for 184 countries between 2013 and 2040. Lancet published online April 13. http://dx.doi.org/10.1016/S0140-6736(16) 30167–2
4. How Public And Private Reforms Dramatically Improved Access To Dialysis Therapy In Malaysia
5. World Health Organization (2013). World health statistics 2013. Geneva: World Health Organization.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献